Trial Profile
Evaluation of Skin Quality Improvement When Hyper-Diluted OnabotulinumtoxinA (Botox, Botox Cosmetic /BTXa/) is Injected Into The Superficial Dermis of the Mid-Face
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Skin abnormalities
- Focus Therapeutic Use
- 20 Feb 2019 Status changed from recruiting to completed.
- 04 Apr 2017 New trial record